Aetna Now Rated a “Conviction Buy” at Goldman Sachs (AET)

By
A A A
Share |

Health benefits provider Aetna Inc. ( AET ) on Monday caught a big upgrade from analysts at Goldman Sachs.

The firm said it added AET to its prestigious "Conviction Buy" list with a $54 price target, suggesting 33% upside to the stock's Friday closing price of $40.63.

Goldman noted its expects Aetna to catch up to its peers in the industry, in terms of valuation. It also lauded AET's strong third quarter earnings results and higher-than-expected 2012 earnings estimates.

Aetna shares posted modest gains in premarket trading Monday.

The Bottom Line
Shares of Aetna ( AET ) have a 1.48% dividend yield, based on Friday's closing stock price of $40.63. The stock has technical support in the $36-$38 price area. If the shares can firm up, we see overhead resistance around the $42-$44 price levels.

Aetna Inc. ( AET ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: AET

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

56,834,794
    $15.52 unch
47,736,761
  • $94.72 ▲ 0.83%
41,992,984
  • $2.47 ▲ 11.76%
40,893,734
  • $34.7901 ▲ 2.14%
39,324,803
  • $69.27 ▼ 0.19%
39,276,613
  • $7.28 ▲ 2.68%
39,084,483
  • $44.83 ▼ 0.01%
33,527,212
  • $26.02 ▲ 0.15%
As of 7/22/2014, 04:03 PM